Strongest FamiliesTM Neurodevelopmental
Launched by IWK HEALTH CENTRE · Feb 6, 2019
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- SCREENING: Parents/caregivers must meet all of the following criteria to be eligible to proceed to Consent:
- • 1. Have a child between 3-14 years of age with a diagnosis of a neurodevelopmental disorder (i.e. Autism Spectrum Disorder, Cerebral Palsy, Epilepsy, Global Developmental Delay, Down Syndrome, Fetal Alcohol Spectrum Disorder (FASD), severe learning disability or any other diagnosis that influences how their child gets around, communicates their ideas, processes what they hear, or remembers things as reported by parents/caregivers).
- • 2. The child has been experiencing behavioural problems that interfere with the activities of daily living (as defined by the caregiver) for at least 6 months prior to study screening.
- • 3. Have been the primary caregiver for a minimum of 6 months prior to entry into the study.
- • 4. Have a reasonable expectation of being be the primary caregiver for at least 10 months after study enrolment.
- • 5. Read, write, and understand English.
- • 6. Have access to a telephone.
- • 7. Have regular access to a tablet, smartphone or computer connected to high speed Internet.
- • 8. Live in Canada.
- • 9. Commit to the requirements of taking part in the study (e.g. available to attend weekly coaching calls, having a Facebook account to access Parent-to-Parent support group)
- Any of the following criteria will exclude individuals from proceeding to Consent:
- • 1. Child is NOT able to understand everyday language and instructions or communicate needs as reported by parent/caregiver.
- • 2. Parent or child has ongoing struggles with symptoms of psychosis, schizophrenia, bipolar disorder or major depression (i.e. the symptoms are not well managed).
- • 3. Child is at imminent risk of serious harm to self or others (i.e. requiring hospitalization or medical attention).
- • 4. Child regularly engages in moderate to severe self-injurious behaviours, as reported by the parent.
- • 5. Child has attempted suicide in the past 6 months.
- • 6. Parent has previously taken part in a Strongest Families Parenting Program.
- • 7. Parent has taken part in Triple P, COPE, Incredible Years or another parent training program within 6 months prior to starting the study.
- BASELINE ASSESSMENT:
- • 1. Meet minimum score of 16 (for ages 2 - 4 years) or 17 (for ages 4-17) on the Total Difficulties Score of the Strengths and Difficulties Questionnaire.
- 2. Meet a minimum level of child's cognitive functioning as determined by the question\* below. Parents must endorse 1, 2 or 3 on the following question:
- • Compared with children of the same age, does your child have difficulty learning things? Would you say your child has: no difficulty, some difficulty, a lot of difficulty or cannot do at all? No difficulty........................ 1 Some difficulty....................2 A lot of difficulty..................3 Cannot do at .....................4
About Iwk Health Centre
IWK Health Centre is a leading pediatric and women's health facility based in Halifax, Nova Scotia, dedicated to providing high-quality care and advancing medical research. As a prominent clinical trial sponsor, IWK Health Centre collaborates with multidisciplinary teams to conduct innovative research aimed at improving health outcomes for children, youth, and women. The center prioritizes patient-centered approaches in its trials, ensuring that the needs and safety of participants are at the forefront of its research initiatives. With a commitment to excellence and ethical standards, IWK Health Centre contributes significantly to the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Trial Officials
Patrick J McGrath, PhD
Principal Investigator
IWK Health Centre
Lucyna Lach, PhD
Principal Investigator
McGill University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials